Heteromerization of Μ-Opioid Receptor and Cholecystokinin B Receptor Through the Third Transmembrane Domain of the Μ-Opioid Receptor Contributes to the Anti-Opioid Effects of Cholecystokinin Octapeptide

Experimental and Molecular Medicine - United States
doi 10.1038/s12276-018-0090-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Subtleties of Μ-Opioid Receptor Phosphorylation

British Journal of Pharmacology
Pharmacology
2011English

Human Μ Opioid Receptor Models With Evaluation of the Accuracy Using the Crystal Structure of the Murine Μ Opioid Receptor

Journal of Anesthesia & Clinical Research
2012English

The Opioid Placebo Analgesia Is Mediated Exclusively Through Μ-Opioid Receptor in Rat

International Journal of Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2013English

Absence of G-Protein Activation by Μ-Opioid Receptor Agonists in the Spinal Cord of Μ-Opioid Receptor Knockout Mice

British Journal of Pharmacology
Pharmacology
1999English

A Μ-Opioid Receptor-Filter Assay

Biochemical Pharmacology
BiochemistryPharmacology
1988English

Molecular Details of the Activation of the Μ Opioid Receptor

Journal of Physical Chemistry B
SurfacesTheoretical ChemistryMaterials ChemistryFilmsMedicineCoatingsPhysical
2013English

Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy Μ Opioid Receptor (MOR) Agonist/Δ Opioid Receptor (DOR) Antagonist Ligands

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

Μ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

PI3Kγ Integrates cAMP and Akt Signalling of the Μ-Opioid Receptor

British Journal of Pharmacology
Pharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy